Angiosarcoma

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Agnostic Therapy in Rare Solid Tumors

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)

Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars

A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma

Propranolol in Angiosarcoma

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma